Condensed Consolidated Statement of Cash Flows (USD $)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Cash Flows from Operating Activities:
Net Income (Loss)	$ (2,434,753)	$ (1,618,549)
Adjustments to reconcile Net Income (Loss) to net cash used in operating activities:
Depreciation and amortization	367,167	604,733
Stock compensation expense	98,006	65,015
Accretion for debt discounts and amortization of issuance costs	202,725	17,118
Shares issued as a conversion of payables	57,500
Shares issued for services, Value	31,144
Changes in operating assets and liabilities:
Change in Accounts receivable	(1,789)	(65,436)
Change in Prepaid expenses and other assets	(12,700)	6,459
Change in Accounts payable	(167,864)	(9,123)
Change in Accrued interest and other liabilities	(51)	(164,298)
Change in Deferred revenue	306,833	37,742
Change in Deferred rent	(5,287)	(7,603)
Net Cash Used In Operating Activities	(1,559,069)	(1,133,942)
Cash Flows From Investing Activities:
Purchase of fixed assets, net of disposal	(26,488)
Deposits for merger		(150,000)
Payment of patent application	(5,000)
Payment of platform development costs	(378,330)	(442,365)
Net Cash Used In Investing Activities	(409,818)	(592,365)
Cash Flows From Financing Activities
Proceeds from notes payable related parties	122,204	534,084
Repayments on notes payable related parties	(192,965)	(132,000)
Payment of convertible note, net of proceeds	(20,106)
Proceeds from exercise of stock options	38,532
Proceeds from debentures, net of issuance costs		424,081
Stock issuance costs		(94,997)
Sale of common stock, net of issuance costs	3,573,100	873,535
Net Cash Provided By Financing Activities	3,520,765	1,604,703
Net Increase (Decrease) in Cash and Cash Equivalents	1,551,878	(121,604)
Cash and Cash Equivalents, Beginning of Period	13,724	123,135
Cash and Cash Equivalents, End of Period	1,565,602	1,531
Non-cash Investing and Financing Transactions:
Interest paid	22,141
Issuance of stock in acquisition of subsidiary		325
Conversion of debt to common stock shares	$ 32,006